These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 23548358)
21. Use of antidepressants for management of hot flashes. Carroll DG; Kelley KW Pharmacotherapy; 2009 Nov; 29(11):1357-74. PubMed ID: 19857151 [TBL] [Abstract][Full Text] [Related]
22. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901 [TBL] [Abstract][Full Text] [Related]
23. Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Ferrari A J Obstet Gynaecol Res; 2009 Dec; 35(6):1083-90. PubMed ID: 20025635 [TBL] [Abstract][Full Text] [Related]
24. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition. Freeman MP; Hirschberg AM; Wang B; Petrillo LF; Connors S; Regan S; Joffe H; Cohen LS Maturitas; 2013 Jun; 75(2):170-4. PubMed ID: 23602542 [TBL] [Abstract][Full Text] [Related]
25. Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause. Morga A; Ajmera M; Gao E; Patterson-Lomba O; Zhao A; Mancuso S; Siddiqui E; Kagan R Menopause; 2024 Jan; 31(1):68-76. PubMed ID: 38016166 [TBL] [Abstract][Full Text] [Related]
26. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial. Bachmann GA; Schaefers M; Uddin A; Utian WH Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008 [TBL] [Abstract][Full Text] [Related]
27. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Reddy SY; Warner H; Guttuso T; Messing S; DiGrazio W; Thornburg L; Guzick DS Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054 [TBL] [Abstract][Full Text] [Related]
28. Use of gabapentin for the management of natural or surgical menopausal hot flashes. Hayes LP; Carroll DG; Kelley KW Ann Pharmacother; 2011 Mar; 45(3):388-94. PubMed ID: 21343402 [TBL] [Abstract][Full Text] [Related]
29. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women. Stevens RE; Hanford K; Wason S; Cusack SL; Phelps KV Int J Fertil Womens Med; 2000; 45(4):264-72. PubMed ID: 10997482 [TBL] [Abstract][Full Text] [Related]
30. Soy extracts versus hormone therapy for reduction of menopausal hot flushes: indirect comparison. Bolaños-Díaz R; Zavala-Gonzales JC; Mezones-Holguín E; Francia-Romero J Menopause; 2011 Jul; 18(7):825-9. PubMed ID: 21358349 [TBL] [Abstract][Full Text] [Related]
31. Effective and clinically meaningful non-hormonal hot flash therapies. Guttuso T Maturitas; 2012 May; 72(1):6-12. PubMed ID: 22377187 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study]. Zhou YZ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Lin SQ Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370 [TBL] [Abstract][Full Text] [Related]
33. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms. Simon JA; Menopause; 2006; 13(2):222-31. PubMed ID: 16645536 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial. Huang AJ; Cummings SR; Ganz P; Schembri M; Raghunathan H; Vittinghoff E; Gibson CJ; Grady D JAMA Intern Med; 2023 Aug; 183(8):776-783. PubMed ID: 37273224 [TBL] [Abstract][Full Text] [Related]
35. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Winther K; Rein E; Hedman C Climacteric; 2005 Jun; 8(2):162-70. PubMed ID: 16096172 [TBL] [Abstract][Full Text] [Related]
36. Use of gabapentin in patients experiencing hot flashes. Brown JN; Wright BR Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798 [TBL] [Abstract][Full Text] [Related]
37. Menopausal hot flushes and night sweats: where are we now? Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495 [TBL] [Abstract][Full Text] [Related]
38. Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder. Perry R; Cassagnol M Clin Ther; 2009 Jun; 31 Pt 1():1374-404. PubMed ID: 19698900 [TBL] [Abstract][Full Text] [Related]
39. Venlafaxine and desvenlafaxine in the management of menopausal hot flashes. Johnson ED; Carroll DG Pharm Pract (Granada); 2011 Jul; 9(3):117-21. PubMed ID: 24367464 [TBL] [Abstract][Full Text] [Related]
40. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy. Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]